ARENSIA Exploratory Medicine Phase I Unit, The Institute of Oncology

Chisinau 2025

0 studies enrolling now · 2 studies all time

What they study most

Advanced Breast Cancer, Breast Cancer, Breast Cancer Female, Breast Neoplasm, Carcinoma, Ductal, Breast, Metastatic Breast Cancer, Small Cell Lung Cancer, Stage IV Breast Cancer

Studies at this site

• G1T48, an Oral SERD, Alone and in Combination With Palbociclib in ER-Positive, HER2-Negative Advanced Breast Cancer — Completed
• Trilaciclib (G1T28), a CDK 4/6 Inhibitor, in Combination With Etoposide and Carboplatin in Extensive Stage Small Cell Lung Cancer (SCLC) — Completed